Evaluation of a low-invasive strategy for prostate cancer screening with prostate-specific antigen

By Barette M.   Renard F.   Peltier A.   van Velthoven R.   Huet F.   Grivegnee A.R.   Autier P.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 712-716

Elsevier

Access to resources Recommend Favorite

Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

By Gilliland F.D.   Hunt W.C.   Key C.R.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer - improvement in performance status, bone pain, and reduction in prostate specific antigen

By Sartor O.   Weinberger M.   Moore A.   Li A.   Figg W.D.  

Urology, Vol. 52, Iss. 2, 1998-08 ,pp. : 252-256

Elsevier

Access to resources Recommend Favorite

Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations

By Ito K.   Kubota Y.   Suzuki K.   Shimizu N.   Fukabori Y.   Kurokawa K.   Imai K.   Yamanaka H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 705-709

Elsevier

Access to resources Recommend Favorite

The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer

By Kiper Ahmet   Yiğitbası Orhan   Imamoglu Abdurrahim   Tuygun Can   Turan Celaleddin  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 571-576

Springer Publishing Company

Access to resources Recommend Favorite